Advertisement

Topics

PAREXEL Collaborates with Sanofi to Advance the use of Wearable Devices

02:30 EDT 22 Jun 2017 | The Journal of mHealth

Leading global biopharmaceutical services organisation, PAREXEL, has announced a collaboration with Sanofi to advance the use of wearable devices to transform the collection of data in clinical trials.Wearables have the potential to address several challenges related to clinical trials and improve execution by increasing patients’ ability to participate, driving patient engagement, and creating more opportunities for decentralised trial sites. The PAREXEL-Sanofi collaboration is designed to

Original Article: PAREXEL Collaborates with Sanofi to Advance the use of Wearable Devices

NEXT ARTICLE

More From BioPortfolio on "PAREXEL Collaborates with Sanofi to Advance the use of Wearable Devices"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Sanofi-Aventis
Sanofi-Aventis is a global pharmaceutical company with annual sales of $40,871m, placing it the second highest in the world. Although Sanofi-Aventis products are for a a very wide range of health problems, their major products are those for diabetes, o...